{"id":17129,"date":"2024-05-29T12:57:19","date_gmt":"2024-05-29T15:57:19","guid":{"rendered":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/"},"modified":"2024-05-29T12:57:19","modified_gmt":"2024-05-29T15:57:19","slug":"forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras","status":"publish","type":"post","link":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/","title":{"rendered":"F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras"},"content":{"rendered":"<p style=\"font-weight: 400;\">A Organiza&ccedil;&atilde;o Mundial da Sa&uacute;de (OMS) classifica as doen&ccedil;as raras como <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/raras.org.br\/doencas\/informacoes-gerais#:~:text=Informa%C3%A7%C3%B5es%20gerais%20sobre%20doen%C3%A7as%20raras&amp;text=Segundo%20a%20OMS%2C%20as%20doen%C3%A7as,at%C3%A9%2010%25%20da%20popula%C3%A7%C3%A3o%20mundial.\">uma prioridade global de sa&uacute;de p&uacute;blica<\/a>. Na <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/health.ec.europa.eu\/european-reference-networks\/rare-diseases_en\">Uni&atilde;o Europeia<\/a>, uma doen&ccedil;a &eacute; considerada rara se afetar 1 em cada 2 mil pessoas. No Brasil, segundo a <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.interfarma.org.br\/interfarma-lanca-estudo-sobre-doencas-raras-no-brasil\/\">Interfarma<\/a> &#8211; Associa&ccedil;&atilde;o da Ind&uacute;stria Farmac&ecirc;utica de Pesquisa, existem cerca de 13 milh&otilde;es de pessoas com essas condi&ccedil;&otilde;es. Com foco no debate sobre novos tratamentos e descobertas cient&iacute;ficas para melhorar o diagn&oacute;stico e o tratamento de doen&ccedil;as raras, o Instituto Brasileiro de A&ccedil;&atilde;o Respons&aacute;vel promove o &#8220;XV F&oacute;rum Nacional de Pol&iacute;ticas de Sa&uacute;de no Brasil &#8211; Doen&ccedil;as Raras&#8221;. O audit&oacute;rio Senador Ant&ocirc;nio Carlos Magalh&atilde;es do Interlegis, localizado no Senado Federal, ser&aacute; palco do evento, no dia 13 de junho, a partir das 9h. O f&oacute;rum &eacute; aberto ao p&uacute;blico com inscri&ccedil;&otilde;es gratuitas no site&nbsp;<a rel=\"nofollow noopener\" target=\"_blank\" href=\"http:\/\/www.acaoresponsavel.org.br\/\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=http:\/\/www.acaoresponsavel.org.br&amp;source=gmail&amp;ust=1716301635786000&amp;usg=AOvVaw2PbCFoCgikfT68Adi-ophk\">www.acaoresponsavel.org.br<\/a>.<\/p>\n<p style=\"font-weight: 400;\">Edilamar Teixeira, Diretora do Ciclo Sa&uacute;de do Instituto Brasileiro de A&ccedil;&atilde;o Respons&aacute;vel, enfatiza que o principal objetivo do f&oacute;rum &eacute; promover a difus&atilde;o de informa&ccedil;&otilde;es sobre doen&ccedil;as raras e destaca que, apesar dos progressos significativos alcan&ccedil;ados, ainda h&aacute; muitas necessidades n&atilde;o atendidas, ressaltando a import&acirc;ncia de continuar os debates. &#8220;Vamos divulgar as mais recentes descobertas cient&iacute;ficas e os avan&ccedil;os cl&iacute;nicos e terap&ecirc;uticos nas &aacute;reas de doen&ccedil;as raras, que atualmente abrangem mais de seis mil tipos e afetam cerca de 8% da popula&ccedil;&atilde;o brasileira. Al&eacute;m disso, especialistas debater&atilde;o as mudan&ccedil;as estruturais necess&aacute;rias e propor&atilde;o solu&ccedil;&otilde;es inovadoras para assegurar, de fato, a sa&uacute;de e a qualidade de vida de todos os pacientes com essas condi&ccedil;&otilde;es no Brasil&#8221;, explica.<\/p>\n<p style=\"font-weight: 400;\">O evento re&uacute;ne representantes de institui&ccedil;&otilde;es do governo, da comunidade acad&ecirc;mica, do setor produtivo e das associa&ccedil;&otilde;es de pacientes, visando facilitar as interlocu&ccedil;&otilde;es entre os gestores p&uacute;blicos e sociedade civil, nas discuss&otilde;es sobre a constru&ccedil;&atilde;o de pol&iacute;ticas, programas e a&ccedil;&otilde;es que venham atender os maiores desafios e anseios das pessoas com doen&ccedil;as raras.<\/p>\n<p style=\"font-weight: 400;\">O &#8220;XV F&oacute;rum Nacional de Pol&iacute;ticas de Sa&uacute;de no Brasil &#8211; Doen&ccedil;as Raras&#8221; conta com o apoio de entidades atuantes na &aacute;rea, como&nbsp;Febrararas, Casa Hunter e Casa dos Raros, al&eacute;m de empresas farmac&ecirc;uticas l&iacute;deres em tratamentos para doen&ccedil;as raras, como Ultragenyx, Vertex, Teva Farmac&ecirc;utica e Takeda.<\/p>\n<p style=\"font-weight: 400;\"><strong>Doen&ccedil;as Raras<br \/><\/strong><a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/bvsms.saude.gov.br\/unidos-pela-mudanca-unidos-pela-equidade-29-02-dia-das-doencas-raras\/\">Segundo a OMS<\/a>, existem de 6 a 8 mil tipos de doen&ccedil;as raras, em que 30% dos pacientes morrem antes dos cinco anos de idade; 75% delas afetam crian&ccedil;as e 80% t&ecirc;m origem gen&eacute;tica. Algumas dessas doen&ccedil;as se manifestam a partir de infec&ccedil;&otilde;es bacterianas ou causas virais, al&eacute;rgicas e ambientais, ou s&atilde;o degenerativas e proliferativas. Juntas, as doen&ccedil;as raras afetam at&eacute; 30 milh&otilde;es de pessoas na Europa e 300 milh&otilde;es em todo o mundo.<\/p>\n<p style=\"font-weight: 400;\"><strong>Servi&ccedil;o: XV F&oacute;rum Nacional de Pol&iacute;ticas de Sa&uacute;de &#8211; Doen&ccedil;as Raras<br \/><\/strong>Data: 13 de junho, quinta-feira &#8211; das 9h &agrave;s 14h<br \/>Local: Senado Federal &#8211; Interlegis &#8211; Audit&oacute;rio Senador Ant&ocirc;nio Carlos Magalh&atilde;es, Via N2 Asa Norte &#8211; Bras&iacute;lia\/DF<br \/>Inscri&ccedil;&otilde;es gratuitas:&nbsp;<a rel=\"nofollow noopener\" target=\"_blank\" href=\"http:\/\/www.acaoresponsavel.org.br\/\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=http:\/\/www.acaoresponsavel.org.br\/&amp;source=gmail&amp;ust=1716301635786000&amp;usg=AOvVaw0dLT-NO7gW4fB2W4pkixoX\">www.acaoresponsavel.org.br<\/a><\/p>\n<p style=\"font-weight: 400;\"><strong>O Instituto Brasileiro de A&ccedil;&atilde;o Respons&aacute;vel<br \/><\/strong>O Instituto Brasileiro de A&ccedil;&atilde;o Respons&aacute;vel, fundado em 1999 e sediado em Bras&iacute;lia, &eacute; uma organiza&ccedil;&atilde;o neutra que busca promover o di&aacute;logo entre os setores p&uacute;blico e privado. Atrav&eacute;s dos programas A&ccedil;&atilde;o Respons&aacute;vel e Economia Socioambiental, o instituto foca em consolidar compromissos com a soberania e o desenvolvimento respons&aacute;vel do Brasil em &aacute;reas como sa&uacute;de, agroneg&oacute;cios e energia. Atuando nacionalmente com alcance internacional, contribui significativamente para a formula&ccedil;&atilde;o de pol&iacute;ticas p&uacute;blicas.<\/p>\n<p><img src='https:\/\/api.dino.com.br\/v2\/news\/tr\/303922?partnerId=3197' alt=\"\" style=\"border:0px;width:1px;height:1px;\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Organiza&ccedil;&atilde;o Mundial da Sa&uacute;de (OMS) classifica as doen&ccedil;as raras como uma prioridade global de sa&uacute;de p&uacute;blica. Na Uni&atilde;o Europeia, uma doen&ccedil;a &eacute; considerada rara se afetar 1 em cada 2 mil pessoas. No Brasil, segundo a Interfarma &#8211; Associa&ccedil;&atilde;o da Ind&uacute;stria Farmac&ecirc;utica de Pesquisa, existem cerca de 13 milh&otilde;es de pessoas com essas condi&ccedil;&otilde;es. [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":17130,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-17129","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"og:description\" content=\"A Organiza&ccedil;&atilde;o Mundial da Sa&uacute;de (OMS) classifica as doen&ccedil;as raras como uma prioridade global de sa&uacute;de p&uacute;blica. Na Uni&atilde;o Europeia, uma doen&ccedil;a &eacute; considerada rara se afetar 1 em cada 2 mil pessoas. No Brasil, segundo a Interfarma &#8211; Associa&ccedil;&atilde;o da Ind&uacute;stria Farmac&ecirc;utica de Pesquisa, existem cerca de 13 milh&otilde;es de pessoas com essas condi&ccedil;&otilde;es. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/\" \/>\n<meta property=\"og:site_name\" content=\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-29T15:57:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ocanal.com\/noticias\/corporativas\/wp-content\/uploads\/2024\/05\/7985be80-7ab9-44cb-b649-ac7b854204df.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"755\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"headline\":\"F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras\",\"datePublished\":\"2024-05-29T15:57:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/\"},\"wordCount\":799,\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/7985be80-7ab9-44cb-b649-ac7b854204df.jpg\",\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/\",\"name\":\"F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/7985be80-7ab9-44cb-b649-ac7b854204df.jpg\",\"datePublished\":\"2024-05-29T15:57:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/7985be80-7ab9-44cb-b649-ac7b854204df.jpg\",\"contentUrl\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/7985be80-7ab9-44cb-b649-ac7b854204df.jpg\",\"width\":755,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\",\"name\":\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"description\":\"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/author\\\/dino\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/","og_locale":"pt_BR","og_type":"article","og_title":"F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","og_description":"A Organiza&ccedil;&atilde;o Mundial da Sa&uacute;de (OMS) classifica as doen&ccedil;as raras como uma prioridade global de sa&uacute;de p&uacute;blica. Na Uni&atilde;o Europeia, uma doen&ccedil;a &eacute; considerada rara se afetar 1 em cada 2 mil pessoas. No Brasil, segundo a Interfarma &#8211; Associa&ccedil;&atilde;o da Ind&uacute;stria Farmac&ecirc;utica de Pesquisa, existem cerca de 13 milh&otilde;es de pessoas com essas condi&ccedil;&otilde;es. [&hellip;]","og_url":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/","og_site_name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","article_published_time":"2024-05-29T15:57:19+00:00","og_image":[{"width":755,"height":500,"url":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-content\/uploads\/2024\/05\/7985be80-7ab9-44cb-b649-ac7b854204df.jpg","type":"image\/jpeg"}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"DINO","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/#article","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/"},"author":{"name":"DINO","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"headline":"F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras","datePublished":"2024-05-29T15:57:19+00:00","mainEntityOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/"},"wordCount":799,"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/#primaryimage"},"thumbnailUrl":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-content\/uploads\/2024\/05\/7985be80-7ab9-44cb-b649-ac7b854204df.jpg","articleSection":["Not\u00edcias Corporativas"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/","url":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/","name":"F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/#primaryimage"},"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/#primaryimage"},"thumbnailUrl":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-content\/uploads\/2024\/05\/7985be80-7ab9-44cb-b649-ac7b854204df.jpg","datePublished":"2024-05-29T15:57:19+00:00","author":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"breadcrumb":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/#primaryimage","url":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-content\/uploads\/2024\/05\/7985be80-7ab9-44cb-b649-ac7b854204df.jpg","contentUrl":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-content\/uploads\/2024\/05\/7985be80-7ab9-44cb-b649-ac7b854204df.jpg","width":755,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/forum-nacional-no-senado-discute-politicas-publicas-para-doencas-raras\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ocanal.com\/noticias\/corporativas\/"},{"@type":"ListItem","position":2,"name":"F\u00f3rum nacional no Senado discute pol\u00edticas p\u00fablicas para Doen\u00e7as Raras"}]},{"@type":"WebSite","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website","url":"https:\/\/ocanal.com\/noticias\/corporativas\/","name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","description":"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ocanal.com\/noticias\/corporativas\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff","name":"DINO","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","caption":"DINO"},"url":"https:\/\/ocanal.com\/noticias\/corporativas\/author\/dino\/"}]}},"_links":{"self":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/17129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/comments?post=17129"}],"version-history":[{"count":0,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/17129\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/media\/17130"}],"wp:attachment":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/media?parent=17129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/categories?post=17129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/tags?post=17129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}